S100A7 and familial pancreatic carcinoma: Interestingly, Liu et al. also reported higher levels of S100A7 in invasive and secondary pancreatic cancer tumors than in primary tumors [21], further supporting the complex role of S100A7 in pancreatic tumor development by switching between tumor suppressor and tumor promotor functions.